NUVATION BIO INC (NUVB) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:NUVB • US67080N1019

5.24 USD
-0.1 (-1.87%)
At close: Jan 30, 2026
5.26 USD
+0.02 (+0.38%)
After Hours: 1/30/2026, 8:09:41 PM
Fundamental Rating

2

Overall NUVB gets a fundamental rating of 2 out of 10. We evaluated NUVB against 191 industry peers in the Pharmaceuticals industry. NUVB has a bad profitability rating. Also its financial health evaluation is rather negative. NUVB is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year NUVB has reported negative net income.
  • NUVB had a negative operating cash flow in the past year.
  • In the past 5 years NUVB always reported negative net income.
  • In the past 5 years NUVB always reported negative operating cash flow.
NUVB Yearly Net Income VS EBIT VS OCF VS FCFNUVB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -100M -200M -300M -400M -500M

1.2 Ratios

  • NUVB has a Return On Assets (-36.15%) which is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of -66.74%, NUVB is in line with its industry, outperforming 45.03% of the companies in the same industry.
Industry RankSector Rank
ROA -36.15%
ROE -66.74%
ROIC N/A
ROA(3y)-44.25%
ROA(5y)-34.58%
ROE(3y)-50.3%
ROE(5y)-38.48%
ROIC(3y)N/A
ROIC(5y)N/A
NUVB Yearly ROA, ROE, ROICNUVB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

  • Looking at the Gross Margin, with a value of 54.26%, NUVB is in the better half of the industry, outperforming 66.49% of the companies in the same industry.
  • NUVB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NUVB Yearly Profit, Operating, Gross MarginsNUVB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

3

2. Health

2.1 Basic Checks

  • NUVB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NUVB has more shares outstanding
  • NUVB has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, NUVB has a worse debt to assets ratio.
NUVB Yearly Shares OutstandingNUVB Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
NUVB Yearly Total Debt VS Total AssetsNUVB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of 1.18, we must say that NUVB is in the distress zone and has some risk of bankruptcy.
  • NUVB has a Altman-Z score (1.18) which is comparable to the rest of the industry.
  • NUVB has a Debt/Equity ratio of 0.61. This is a neutral value indicating NUVB is somewhat dependend on debt financing.
  • The Debt to Equity ratio of NUVB (0.61) is worse than 67.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Altman-Z 1.18
ROIC/WACCN/A
WACC9.42%
NUVB Yearly LT Debt VS Equity VS FCFNUVB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 8.48 indicates that NUVB has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 8.48, NUVB is in the better half of the industry, outperforming 74.87% of the companies in the same industry.
  • NUVB has a Quick Ratio of 8.39. This indicates that NUVB is financially healthy and has no problem in meeting its short term obligations.
  • NUVB has a Quick ratio of 8.39. This is in the better half of the industry: NUVB outperforms 75.39% of its industry peers.
Industry RankSector Rank
Current Ratio 8.48
Quick Ratio 8.39
NUVB Yearly Current Assets VS Current LiabilitesNUVB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

  • NUVB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.84%.
  • The Revenue has grown by 1137.19% in the past year. This is a very strong growth!
EPS 1Y (TTM)-48.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.67%
Revenue 1Y (TTM)1137.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1704.68%

3.2 Future

  • The Earnings Per Share is expected to grow by 53.75% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 202.98% on average over the next years. This is a very strong growth
EPS Next Y-16.6%
EPS Next 2Y0.45%
EPS Next 3Y18.24%
EPS Next 5Y53.75%
Revenue Next Year2392.77%
Revenue Next 2Y760.39%
Revenue Next 3Y423.77%
Revenue Next 5Y202.98%

3.3 Evolution

NUVB Yearly Revenue VS EstimatesNUVB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
NUVB Yearly EPS VS EstimatesNUVB Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 -2 3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NUVB. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NUVB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NUVB Price Earnings VS Forward Price EarningsNUVB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NUVB Per share dataNUVB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

  • NUVB's earnings are expected to grow with 18.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.45%
EPS Next 3Y18.24%

More info and screens

0

5. Dividend

5.1 Amount

  • NUVB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

NUVATION BIO INC / NUVB FAQ

What is the ChartMill fundamental rating of NUVATION BIO INC (NUVB) stock?

ChartMill assigns a fundamental rating of 2 / 10 to NUVB.


Can you provide the valuation status for NUVATION BIO INC?

ChartMill assigns a valuation rating of 0 / 10 to NUVATION BIO INC (NUVB). This can be considered as Overvalued.


How profitable is NUVATION BIO INC (NUVB) stock?

NUVATION BIO INC (NUVB) has a profitability rating of 1 / 10.